{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptSortName=CaTreasury&answer.isMinisterialCorrection=false&answer.answeringMemberPrinted=Greg+Hands", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptSortName=CaTreasury&answer.isMinisterialCorrection=false&answer.answeringMemberPrinted=Greg+Hands", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptSortName=CaTreasury&answer.isMinisterialCorrection=false&_metadata=all&answer.answeringMemberPrinted=Greg+Hands", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&answeringDeptSortName=CaTreasury&answer.isMinisterialCorrection=false&answer.answeringMemberPrinted=Greg+Hands", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptSortName=CaTreasury&answer.isMinisterialCorrection=false&answer.answeringMemberPrinted=Greg+Hands", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptSortName=CaTreasury&answer.isMinisterialCorrection=false&answer.answeringMemberPrinted=Greg+Hands", "items" : [{"_about" : "http://data.parliament.uk/resources/533642", "AnsweringBody" : [{"_value" : "HM Treasury"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/533642/answer", "answerText" : {"_value" : "
Horizon 2020 is the main EU Research and Innovation programme. The European Commission made the following statement on 4 July 2016:<\/p>
<\/p>
\u201cThe Statement of 29 June of the Heads of State or Government of 27 Member States, as well as the Presidents of the European Council and the European Commission, confirms that until the UK leaves the EU, EU law continues to apply to and within the UK, both when it comes to rights and obligations. This includes the eligibility of UK legal entities to participate and receive funding in Horizon 2020 actions.\u201d<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1526", "label" : {"_value" : "Biography information for Greg Hands"} } , "answeringMemberConstituency" : {"_value" : "Chelsea and Fulham"} , "answeringMemberPrinted" : {"_value" : "Greg Hands"} , "dateOfAnswer" : {"_value" : "2016-07-14", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-07-14T09:18:01.557Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "14"} , "answeringDeptShortName" : {"_value" : "Treasury"} , "answeringDeptSortName" : {"_value" : "CaTreasury"} , "date" : {"_value" : "2016-07-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Science: Finance"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask Mr Chancellor of the Exchequer, if he will make it his policy to replace any reductions in private investment and access to EU research grants occurring as a result of the vote to leave the EU by increasing the science budget.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4382", "label" : {"_value" : "Biography information for Daniel Zeichner"} } , "tablingMemberConstituency" : {"_value" : "Cambridge"} , "tablingMemberPrinted" : [{"_value" : "Daniel Zeichner"} ], "uin" : "42201"} , {"_about" : "http://data.parliament.uk/resources/533299", "AnsweringBody" : [{"_value" : "HM Treasury"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/533299/answer", "answerText" : {"_value" : "
The award of £5 million for Mesothelioma to establish a National Centre for Mesothelioma Research was in response to an application for charitable funds in order to urgently address the anticipated imminent high mortality rate amongst Royal Navy Veterans and dockyard workers. The Chancellor of the Exchequer has made a series of Banking Fines announcements since October 2012. Throughout all of these his intention has always been that the fines would be allocated to good causes including Military and Emergency Services charities and related good causes that represent the \u2018best of values\u2019. This award was committed by the Chancellor in accordance with his intent for the use of LIBOR fines articulated above.<\/p>
<\/p>
The National Mesothelioma Centre, to which the funds have been committed, will be a collaboration between four leading institutions which have a major interest in the treatment of mesothelioma: the National Heart and Lung Institute (NHLI) at Imperial College, the Royal Brompton Hospital, the Institute of Cancer Research (ICR), and the Royal Marsden Hospital. Scientists at NHLI and ICR have considerable expertise in the discovery of the genetic mutations which cause cancer, including mesothelioma, and in particular in the identification of \u2018driver\u2019 mutations which can be potential targets for new treatments. ICR has considerable experience of pulling through novel therapies into clinical practice. Their NHS partner hospitals - Royal Brompton and Royal Marsden Hospitals as national specialist centres have mesothelioma patients referred to them from across the UK. This collaboration will form the hub of the Centre whose spokes will engage all other hospitals in the UK to which mesotheliomas are referred and treated. This will thus form the basis of a network to enable rapid evaluation of potential new treatments. The funds therefore have been committed to establish a National Centre for Mesothelioma research, rather than to just 4 specific hospitals/research centres.<\/p>
<\/p>
Professor Sir Anthony Newman Taylor, the driving force behind the application, has, as per his original intention stated in his funding application, engaged across the Mesothelioma community, with a view to forming a steering group for the centre. Those he has contacted include: the British Lung Foundation, who have offered to fund raise with the centre for further resources for mesothelioma research; Ms Liz Darlison, of Mesothelioma UK; the June Hancock Mesothelioma Research Fund; and the Asbestos Victims Support Groups Forum; Dr Robert Rintoul from Cambridge University; Prof Anne Willis and Marion Macfarlane and Dr John Le Quesne from Leicester University; and Prof Luciano Mutti from Manchester University. They have all expressed their support for the intention that these funds be used as a platform to foster collaborative research into an effective treatment for mesothelioma across the UK.<\/p>
<\/p>
The grant to the National Mesothelioma Centre is subject to standard grant terms and conditions including a reporting requirement to ensure that the funds are used as intended. It is not policy to publish all documentation relating to LIBOR awards, due to the large number of applications and associated correspondence.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1526", "label" : {"_value" : "Biography information for Greg Hands"} } , "answeringMemberConstituency" : {"_value" : "Chelsea and Fulham"} , "answeringMemberPrinted" : {"_value" : "Greg Hands"} , "dateOfAnswer" : {"_value" : "2016-07-14", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "42064"} , {"_value" : "42066"} , {"_value" : "42067"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-07-14T09:20:33.44Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "14"} , "answeringDeptShortName" : {"_value" : "Treasury"} , "answeringDeptSortName" : {"_value" : "CaTreasury"} , "date" : {"_value" : "2016-07-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mesothelioma: Research"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask Mr Chancellor of the Exchequer, with reference to paragraph 2.15 of the Budget 2016, on funding for mesothelioma research, what criteria his Department used to make its decision on awarding that funding to four institutions centred around Imperial College.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4031", "label" : {"_value" : "Biography information for Rachel Reeves"} } , "tablingMemberConstituency" : {"_value" : "Leeds West"} , "tablingMemberPrinted" : [{"_value" : "Rachel Reeves"} ], "uin" : "42065"} , {"_about" : "http://data.parliament.uk/resources/533300", "AnsweringBody" : [{"_value" : "HM Treasury"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/533300/answer", "answerText" : {"_value" : "
The award of £5 million for Mesothelioma to establish a National Centre for Mesothelioma Research was in response to an application for charitable funds in order to urgently address the anticipated imminent high mortality rate amongst Royal Navy Veterans and dockyard workers. The Chancellor of the Exchequer has made a series of Banking Fines announcements since October 2012. Throughout all of these his intention has always been that the fines would be allocated to good causes including Military and Emergency Services charities and related good causes that represent the \u2018best of values\u2019. This award was committed by the Chancellor in accordance with his intent for the use of LIBOR fines articulated above.<\/p>
<\/p>
The National Mesothelioma Centre, to which the funds have been committed, will be a collaboration between four leading institutions which have a major interest in the treatment of mesothelioma: the National Heart and Lung Institute (NHLI) at Imperial College, the Royal Brompton Hospital, the Institute of Cancer Research (ICR), and the Royal Marsden Hospital. Scientists at NHLI and ICR have considerable expertise in the discovery of the genetic mutations which cause cancer, including mesothelioma, and in particular in the identification of \u2018driver\u2019 mutations which can be potential targets for new treatments. ICR has considerable experience of pulling through novel therapies into clinical practice. Their NHS partner hospitals - Royal Brompton and Royal Marsden Hospitals as national specialist centres have mesothelioma patients referred to them from across the UK. This collaboration will form the hub of the Centre whose spokes will engage all other hospitals in the UK to which mesotheliomas are referred and treated. This will thus form the basis of a network to enable rapid evaluation of potential new treatments. The funds therefore have been committed to establish a National Centre for Mesothelioma research, rather than to just 4 specific hospitals/research centres.<\/p>
<\/p>
Professor Sir Anthony Newman Taylor, the driving force behind the application, has, as per his original intention stated in his funding application, engaged across the Mesothelioma community, with a view to forming a steering group for the centre. Those he has contacted include: the British Lung Foundation, who have offered to fund raise with the centre for further resources for mesothelioma research; Ms Liz Darlison, of Mesothelioma UK; the June Hancock Mesothelioma Research Fund; and the Asbestos Victims Support Groups Forum; Dr Robert Rintoul from Cambridge University; Prof Anne Willis and Marion Macfarlane and Dr John Le Quesne from Leicester University; and Prof Luciano Mutti from Manchester University. They have all expressed their support for the intention that these funds be used as a platform to foster collaborative research into an effective treatment for mesothelioma across the UK.<\/p>
<\/p>
The grant to the National Mesothelioma Centre is subject to standard grant terms and conditions including a reporting requirement to ensure that the funds are used as intended. It is not policy to publish all documentation relating to LIBOR awards, due to the large number of applications and associated correspondence.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1526", "label" : {"_value" : "Biography information for Greg Hands"} } , "answeringMemberConstituency" : {"_value" : "Chelsea and Fulham"} , "answeringMemberPrinted" : {"_value" : "Greg Hands"} , "dateOfAnswer" : {"_value" : "2016-07-14", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "42064"} , {"_value" : "42065"} , {"_value" : "42067"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-07-14T09:20:33.517Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "14"} , "answeringDeptShortName" : {"_value" : "Treasury"} , "answeringDeptSortName" : {"_value" : "CaTreasury"} , "date" : {"_value" : "2016-07-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mesothelioma: Research"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask Mr Chancellor of the Exchequer, with reference to paragraph 2.15 of the Budget 2016, on funding for mesothelioma research, what consultation his Department conducted with stakeholders before the decision was taken to award that funding to four institutions centred around Imperial College.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4031", "label" : {"_value" : "Biography information for Rachel Reeves"} } , "tablingMemberConstituency" : {"_value" : "Leeds West"} , "tablingMemberPrinted" : [{"_value" : "Rachel Reeves"} ], "uin" : "42066"} , {"_about" : "http://data.parliament.uk/resources/533301", "AnsweringBody" : [{"_value" : "HM Treasury"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/533301/answer", "answerText" : {"_value" : "
The award of £5 million for Mesothelioma to establish a National Centre for Mesothelioma Research was in response to an application for charitable funds in order to urgently address the anticipated imminent high mortality rate amongst Royal Navy Veterans and dockyard workers. The Chancellor of the Exchequer has made a series of Banking Fines announcements since October 2012. Throughout all of these his intention has always been that the fines would be allocated to good causes including Military and Emergency Services charities and related good causes that represent the \u2018best of values\u2019. This award was committed by the Chancellor in accordance with his intent for the use of LIBOR fines articulated above.<\/p>
<\/p>
The National Mesothelioma Centre, to which the funds have been committed, will be a collaboration between four leading institutions which have a major interest in the treatment of mesothelioma: the National Heart and Lung Institute (NHLI) at Imperial College, the Royal Brompton Hospital, the Institute of Cancer Research (ICR), and the Royal Marsden Hospital. Scientists at NHLI and ICR have considerable expertise in the discovery of the genetic mutations which cause cancer, including mesothelioma, and in particular in the identification of \u2018driver\u2019 mutations which can be potential targets for new treatments. ICR has considerable experience of pulling through novel therapies into clinical practice. Their NHS partner hospitals - Royal Brompton and Royal Marsden Hospitals as national specialist centres have mesothelioma patients referred to them from across the UK. This collaboration will form the hub of the Centre whose spokes will engage all other hospitals in the UK to which mesotheliomas are referred and treated. This will thus form the basis of a network to enable rapid evaluation of potential new treatments. The funds therefore have been committed to establish a National Centre for Mesothelioma research, rather than to just 4 specific hospitals/research centres.<\/p>
<\/p>
Professor Sir Anthony Newman Taylor, the driving force behind the application, has, as per his original intention stated in his funding application, engaged across the Mesothelioma community, with a view to forming a steering group for the centre. Those he has contacted include: the British Lung Foundation, who have offered to fund raise with the centre for further resources for mesothelioma research; Ms Liz Darlison, of Mesothelioma UK; the June Hancock Mesothelioma Research Fund; and the Asbestos Victims Support Groups Forum; Dr Robert Rintoul from Cambridge University; Prof Anne Willis and Marion Macfarlane and Dr John Le Quesne from Leicester University; and Prof Luciano Mutti from Manchester University. They have all expressed their support for the intention that these funds be used as a platform to foster collaborative research into an effective treatment for mesothelioma across the UK.<\/p>
<\/p>
The grant to the National Mesothelioma Centre is subject to standard grant terms and conditions including a reporting requirement to ensure that the funds are used as intended. It is not policy to publish all documentation relating to LIBOR awards, due to the large number of applications and associated correspondence.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1526", "label" : {"_value" : "Biography information for Greg Hands"} } , "answeringMemberConstituency" : {"_value" : "Chelsea and Fulham"} , "answeringMemberPrinted" : {"_value" : "Greg Hands"} , "dateOfAnswer" : {"_value" : "2016-07-14", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "42065"} , {"_value" : "42066"} , {"_value" : "42067"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-07-14T09:20:33.363Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "14"} , "answeringDeptShortName" : {"_value" : "Treasury"} , "answeringDeptSortName" : {"_value" : "CaTreasury"} , "date" : {"_value" : "2016-07-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mesothelioma: Research"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask Mr Chancellor of the Exchequer, with reference to paragraph 2.15 of the Budget 2016, on funding for mesothelioma research, who in his Department is responsible for the decision to award that funding to four institutions centred around Imperial College.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4031", "label" : {"_value" : "Biography information for Rachel Reeves"} } , "tablingMemberConstituency" : {"_value" : "Leeds West"} , "tablingMemberPrinted" : [{"_value" : "Rachel Reeves"} ], "uin" : "42064"} , {"_about" : "http://data.parliament.uk/resources/533302", "AnsweringBody" : [{"_value" : "HM Treasury"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/533302/answer", "answerText" : {"_value" : "
The award of £5 million for Mesothelioma to establish a National Centre for Mesothelioma Research was in response to an application for charitable funds in order to urgently address the anticipated imminent high mortality rate amongst Royal Navy Veterans and dockyard workers. The Chancellor of the Exchequer has made a series of Banking Fines announcements since October 2012. Throughout all of these his intention has always been that the fines would be allocated to good causes including Military and Emergency Services charities and related good causes that represent the \u2018best of values\u2019. This award was committed by the Chancellor in accordance with his intent for the use of LIBOR fines articulated above.<\/p>
<\/p>
The National Mesothelioma Centre, to which the funds have been committed, will be a collaboration between four leading institutions which have a major interest in the treatment of mesothelioma: the National Heart and Lung Institute (NHLI) at Imperial College, the Royal Brompton Hospital, the Institute of Cancer Research (ICR), and the Royal Marsden Hospital. Scientists at NHLI and ICR have considerable expertise in the discovery of the genetic mutations which cause cancer, including mesothelioma, and in particular in the identification of \u2018driver\u2019 mutations which can be potential targets for new treatments. ICR has considerable experience of pulling through novel therapies into clinical practice. Their NHS partner hospitals - Royal Brompton and Royal Marsden Hospitals as national specialist centres have mesothelioma patients referred to them from across the UK. This collaboration will form the hub of the Centre whose spokes will engage all other hospitals in the UK to which mesotheliomas are referred and treated. This will thus form the basis of a network to enable rapid evaluation of potential new treatments. The funds therefore have been committed to establish a National Centre for Mesothelioma research, rather than to just 4 specific hospitals/research centres.<\/p>
<\/p>
Professor Sir Anthony Newman Taylor, the driving force behind the application, has, as per his original intention stated in his funding application, engaged across the Mesothelioma community, with a view to forming a steering group for the centre. Those he has contacted include: the British Lung Foundation, who have offered to fund raise with the centre for further resources for mesothelioma research; Ms Liz Darlison, of Mesothelioma UK; the June Hancock Mesothelioma Research Fund; and the Asbestos Victims Support Groups Forum; Dr Robert Rintoul from Cambridge University; Prof Anne Willis and Marion Macfarlane and Dr John Le Quesne from Leicester University; and Prof Luciano Mutti from Manchester University. They have all expressed their support for the intention that these funds be used as a platform to foster collaborative research into an effective treatment for mesothelioma across the UK.<\/p>
<\/p>
The grant to the National Mesothelioma Centre is subject to standard grant terms and conditions including a reporting requirement to ensure that the funds are used as intended. It is not policy to publish all documentation relating to LIBOR awards, due to the large number of applications and associated correspondence.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1526", "label" : {"_value" : "Biography information for Greg Hands"} } , "answeringMemberConstituency" : {"_value" : "Chelsea and Fulham"} , "answeringMemberPrinted" : {"_value" : "Greg Hands"} , "dateOfAnswer" : {"_value" : "2016-07-14", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "42064"} , {"_value" : "42065"} , {"_value" : "42066"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-07-14T09:20:33.597Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "14"} , "answeringDeptShortName" : {"_value" : "Treasury"} , "answeringDeptSortName" : {"_value" : "CaTreasury"} , "date" : {"_value" : "2016-07-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mesothelioma: Research"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask Mr Chancellor of the Exchequer, with reference to paragraph 2.15 of the Budget 2016, on funding for mesothelioma research, if he will publish all the documents his Department hold related to the decision to award that funding to four institutions centred around Imperial College.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4031", "label" : {"_value" : "Biography information for Rachel Reeves"} } , "tablingMemberConstituency" : {"_value" : "Leeds West"} , "tablingMemberPrinted" : [{"_value" : "Rachel Reeves"} ], "uin" : "42067"} , {"_about" : "http://data.parliament.uk/resources/533323", "AnsweringBody" : [{"_value" : "HM Treasury"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/533323/answer", "answerText" : {"_value" : "